Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast CancerShaokun Shu, Kornélia Polyák, Katherine C. Murphy et al.|Molecular Cell|2020Cited by 207
Acquired resistance to combined BET and CDK4/6 inhibition in triple-negative breast cancerJennifer Y. Ge, Kornélia Polyák, Shaokun Shu et al.|Nature Communications|2020Cited by 97
Heterogeneity and transcriptional drivers of triple-negative breast cancerBojana Jovanović, Kornélia Polyák, Daniel Temko et al.|Cell Reports|2023Cited by 29